Terumo (OTCMKTS:TRUMY) Sees Strong Trading Volume – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY) shares saw strong trading volume on Thursday . 2,049,380 shares changed hands during trading, an increase of 303% from the previous session’s volume of 508,467 shares.The stock last traded at $12.73 and had previously closed at $12.67.

Terumo Stock Down 0.8%

The company has a current ratio of 2.51, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07. The business has a fifty day simple moving average of $13.96 and a two-hundred day simple moving average of $15.76. The company has a market cap of $18.67 billion, a PE ratio of 21.83 and a beta of 0.74.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The business had revenue of $1.94 billion during the quarter, compared to analyst estimates of $1.82 billion. Terumo had a net margin of 11.74% and a return on equity of 9.13%.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.